<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Infectious diseases</title>
            <link>https://medicalxpress.com/infectious-diseases-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Infectious diseases</description>

                            <item>
                    <title>Early respiratory infections may explain half of younger siblings&#039; earnings gap</title>
                    <description>Younger siblings are often portrayed as reckless, scatterbrained and less put-together than their older siblings. Social science researchers have underpinned these portrayals with data, showing that younger siblings obtain, on average, slightly less education and earn slightly less in adulthood.</description>
                    <link>https://medicalxpress.com/news/2026-07-early-respiratory-infections-younger-siblings.html</link>
                    <category></category>
                    <pubDate>Sun, 26 Jul 2026 10:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news704030552</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/siblings.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Dealing with post-pandemic sleep issues—it&#039;s not too late</title>
                    <description>Disrupted sleep and anxiety may be ongoing issues for many people after the pandemic, whether due to COVID-19 directly or to the stress and anxiety caused by the global pandemic, and may contribute to the fatigue commonly reported by people with Post-COVID-19 Syndrome (PCS, or &quot;long COVID&quot;).</description>
                    <link>https://medicalxpress.com/news/2026-07-pandemic-issues-late.html</link>
                    <category></category>
                    <pubDate>Sat, 25 Jul 2026 12:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news704030805</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/fatigue-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Licensed Zaire Ebola vaccine may offer partial protection against Bundibugyo outbreak</title>
                    <description>Ebolaviruses are among the most dangerous known human pathogens. Three ebolavirus species have repeatedly caused major disease outbreaks on the African continent. Most outbreaks have been caused by Zaire ebolavirus. Vaccines and therapeutics are available for this virus species. In contrast, no therapeutics or vaccines are currently available against Bundibugyo ebolavirus, which is responsible for the ongoing outbreak in the Democratic Republic of the Congo and Uganda. This significantly complicates efforts to control the outbreak, which is already the largest documented Bundibugyo ebolavirus outbreak to date.</description>
                    <link>https://medicalxpress.com/news/2026-07-zaire-ebola-vaccine-partial-bundibugyo.html</link>
                    <category></category>
                    <pubDate>Fri, 24 Jul 2026 17:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news704113752</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/licensed-zaire-ebola-v.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experimental plague vaccine strategy protects mice with missing key immune defenses</title>
                    <description>The plague has killed more people than World War II. The bacterium Yersinia pestis (Yp), which causes plague, has triggered three major pandemics throughout history, leaving behind a casualty toll of more than 200 million people. Although the plague no longer causes pandemics on the scale seen in history, it still occurs in many parts of the world today. Vaccination remains our best defense against the disease, but approved options remain scarce.</description>
                    <link>https://medicalxpress.com/news/2026-07-experimental-plague-vaccine-strategy-mice.html</link>
                    <category></category>
                    <pubDate>Fri, 24 Jul 2026 11:00:11 EDT</pubDate>
                    <guid isPermaLink="false">news704105200</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-experimental-plagu.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Oral antiviral blocks airborne measles-like virus spread in ferret model</title>
                    <description>A new oral antiviral drug candidate, administered either before or after direct-contact or airborne exposure to canine distemper virus, which causes measles-like disease in ferrets, blocks virus transmission and reduces clinical symptoms, according to a study published in the journal Nature Microbiology by researchers at the Center for Translational Antiviral Research (CTAR) at Georgia State University.</description>
                    <link>https://medicalxpress.com/news/2026-07-oral-antiviral-blocks-airborne-measles.html</link>
                    <category></category>
                    <pubDate>Fri, 24 Jul 2026 10:40:08 EDT</pubDate>
                    <guid isPermaLink="false">news704105080</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/oral-antiviral-blocks-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Molecular imaging enhances diagnosis of fever of unknown origin</title>
                    <description>PET/CT can add valuable information to aid the diagnosis of fever of unknown origin (FUO), according to a new multicenter, retrospective study published in the June issue of The Journal of Nuclear Medicine. In a cohort of more than 900 FUO patients, molecular imaging directly influenced clinical management in nearly 75%, contributing to improved patient outcomes, increased patient safety and reduced health care costs.</description>
                    <link>https://medicalxpress.com/news/2026-07-molecular-imaging-diagnosis-fever-unknown.html</link>
                    <category></category>
                    <pubDate>Thu, 23 Jul 2026 19:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news704045701</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/molecular-imaging-enha.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Children with severe pneumonia can leave hospital sooner after switching to oral antibiotics, trial shows</title>
                    <description>Children hospitalized with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover, allowing many to return home sooner and complete treatment outside the hospital. That is according to a major international clinical trial led by researchers from City St George&#039;s, University of London, UCL Innovative Clinical Trials Unit, and partners across Africa and Europe. The results are published in The Lancet.</description>
                    <link>https://medicalxpress.com/news/2026-07-children-severe-pneumonia-hospital-sooner.html</link>
                    <category></category>
                    <pubDate>Thu, 23 Jul 2026 18:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news704045341</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/black-kids.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>From urinary tract infection to brain abscess: How bacterial subpopulations can spread to distant body sites</title>
                    <description>Researchers from the University of Cologne, the German Center for Infection Research (DZIF), and the Broad Institute of Harvard and MIT present a clinical case in the New England Journal of Medicine that provides new insights into the evolution of bacterial pathogens and presents the concept of heterovirulence, or the simultaneous presence of subpopulations with different levels of virulence within a single infection.</description>
                    <link>https://medicalxpress.com/news/2026-07-urinary-tract-infection-brain-abscess.html</link>
                    <category></category>
                    <pubDate>Thu, 23 Jul 2026 16:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news704037241</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/from-urinary-tract-inf.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Two new therapies and rapid tests could reshape drug-resistant gonorrhea care</title>
                    <description>Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial-resistant threats to public health worldwide. Clinicians expect to be confronted by rising rates of treatment failure in the years to come.</description>
                    <link>https://medicalxpress.com/news/2026-07-therapies-rapid-reshape-drug-resistant.html</link>
                    <category></category>
                    <pubDate>Thu, 23 Jul 2026 14:20:11 EDT</pubDate>
                    <guid isPermaLink="false">news704030779</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/gonorrhea.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How a pandemic detour helped researchers uncover clues to a mysterious disease</title>
                    <description>When the COVID-19 pandemic shut down international travel in 2020, Michigan State University researcher Eric Benbow faced a problem. A $2.5 million research project designed to study an environmental pathogen in South America was suddenly on hold. With fieldwork canceled and uncertainty surrounding when travel might resume, Benbow and his collaborators needed a new plan.</description>
                    <link>https://medicalxpress.com/news/2026-07-pandemic-detour-uncover-clues-mysterious.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Jul 2026 16:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news703947481</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-a-pandemic-detour.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A single RSV shot emerges as a promising new shield for infants at risk of severe disease</title>
                    <description>Viral infections that attack the lungs are among the leading reasons infants are hospitalized. A new treatment may offer protection against these infections that is as effective and safe as existing options but requires far fewer injections. The Phase III SMART clinical trial investigated the safety and efficacy of clesrovimab (brand name ENFLONSIA), a long-acting medicine designed to protect babies from respiratory syncytial virus (RSV).</description>
                    <link>https://medicalxpress.com/news/2026-07-rsv-shot-emerges-shield-infants.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Jul 2026 11:50:01 EDT</pubDate>
                    <guid isPermaLink="false">news703934345</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-single-rsv-shot-emer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>The lone star tick is bringing another infection concern, the Bourbon virus</title>
                    <description>Tick-borne diseases are common throughout the United States, and most cases are treated effectively. A rarely diagnosed tick-borne infection, the Bourbon virus, transmitted by the common lone star tick, could soon begin to complicate diagnoses if it becomes more prevalent this summer and in coming years.</description>
                    <link>https://medicalxpress.com/news/2026-07-lone-star-infection-bourbon-virus.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Jul 2026 09:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news703929361</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/the-lone-star-tick-is.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Nearly all countries overuse powerful antibiotics, global study finds</title>
                    <description>Certain antibiotics are overused in most countries, while too few people receive the specific antibiotic treatments they need, according to a study of antibiotic use across 186 countries published in The Lancet Public Health journal. The study provides scientific estimates of how many and which types of antibiotics each country could be expected to use ideally, based on local rates of infection and antibiotic resistance.</description>
                    <link>https://medicalxpress.com/news/2026-07-countries-overuse-powerful-antibiotics-global.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Jul 2026 08:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news703925405</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/nearly-all-countries-o.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>&#039;Cellular behavioromics&#039; reveals how immune cells swarm during sepsis</title>
                    <description>Despite the best efforts of intensive care unit (ICU) staff and physicians and the most advanced life support, Dr. Bryan Yipp, witnesses many deaths in the ICU attributed to sepsis. &quot;Sepsis is the body&#039;s overwhelming immune response to an infection, and sometimes that response can cause death,&quot; says Yipp, a critical care physician and clinician-scientist at the Cumming School of Medicine. &quot;While many cases involve people with long-term illnesses, seemingly healthy people can be at work or home one moment and then, within hours, be admitted to the ICU.&quot;</description>
                    <link>https://medicalxpress.com/news/2026-07-cellular-behavioromics-reveals-immune-cells.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Jul 2026 16:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news703863796</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-methodology-coined.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Long non-coding RNA emerges as a &#039;kill switch&#039; for macrophages</title>
                    <description>Macrophages are considered the &quot;scavenger cells&quot; of the immune system, but some pathogens exploit these very cells as hiding places. Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and Philipps-Universität Marburg have discovered a mechanism that helps immune cells balance their response to infection: a long noncoding ribonucleic acid called SAILR that acts as an apoptosis regulator. The findings were published in the journal PNAS.</description>
                    <link>https://medicalxpress.com/news/2026-07-coding-rna-emerges-macrophages.html</link>
                    <category></category>
                    <pubDate>Mon, 20 Jul 2026 16:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news703778402</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/laboratory.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Last-line antibiotics at risk as children&#039;s resistance rises</title>
                    <description>Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life-saving antibiotics, according to the world&#039;s first monitoring platform. The study, led by Murdoch Children&#039;s Research Institute (MCRI) in collaboration with the University of Sydney, Clinton Health Access Initiative (CHAI) and The Chinese University of Hong Kong, analyzed more than 106,000 infection samples from children aged up to 18 years across 82 countries.</description>
                    <link>https://medicalxpress.com/news/2026-07-line-antibiotics-children-resistance.html</link>
                    <category></category>
                    <pubDate>Mon, 20 Jul 2026 15:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news703776420</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/7-children.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study reveals why key antiviral defenses failed in some severe COVID-19 patients</title>
                    <description>Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, causing at least 3 million deaths worldwide, according to the latest estimates by the World Health Organization (WHO).</description>
                    <link>https://medicalxpress.com/news/2026-07-reveals-key-antiviral-defenses-severe.html</link>
                    <category></category>
                    <pubDate>Mon, 20 Jul 2026 14:40:10 EDT</pubDate>
                    <guid isPermaLink="false">news703773640</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-reveals-why-key-1.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
